Q10 PLUS 90 CAPS
53.30€
Pas en stock. En réapprovisionnement.
Description
Q10 Plus is een formule die speciaal ontworpen werd om de hartfunctie en de bloedsomloop te ondersteunen. Q10 Plus bevat, naast co-enzym Q10, taurine, Crataegus oxyacantha (tweestijlige meidoorn), magnesium, Ginkgo biloba en Lmethionine. Hartweefsel bevat hoge concentraties aan taurine. De bessen en bloesems van tweestijlige meidoorn worden al sinds eeuwen gebruikt om de hartfunctie te verzorgen. Crateagus oxycantha werkt verkwikkend voor het hart, is gunstig voor de bloedsomloop en houdt de normale bloeddruk in stand. Magnesium is zeer belangrijk voor het in stand houden van de cardiovasculaire gezondheid. Ginkgo biloba optimaliseert zowel de perifere als de arteriële doorbloeding. L-methionine is een lipotroop aminozuur.
1 capsule per dag of zoals aanbevolen
-
Degenring FH, Suter A, Weber M, Saller R A randomised double blind placebo controlled clinical trial of a standardised extract of fresh
Crataegus berries (Crataegisan) in the treatment of patients with congestive
heart failure NYHA II.Phytomedicine. 2003;10(5):363-9. -
Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J Possible Cause
of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action. J
Cardiovasc Pharmacol. 2003 May;41(5):751-9 -
Takahashi K, Ohyabu Y, Takahashi K, Solodushko V, Takatani T, Itoh T,
Schaffer SW, Azuma J. Taurine renders the cell resistant to ischemia-induced
injury in cultured neonatal rat cardiomyocytes.J Cardiovasc Pharmacol. 2003
May;41(5):726-33. -
Sarter B Coenzyme Q10 and cardiovascular disease: a review. J
Cardiovasc Nurs. 2002 Jul;16(4):9-20. Review. -
Atar D., Mortensen S.A., Flachs H., Herzog W.R. Coenzyme Q10 Protects
Ischemic Myocardium in an Open-Chest Swine Model. Clin. Investig., 1993, 71
:S103-S111. -
Baggio E., Gandini R., Plancher C., Passeri N., Carmosino G. Italian
Multi-Centre Study on the Safety and Efficacy of Coenzyme Q10 as Adjuvant
Therapy in Heart Failure. Clin. Investig., 1993, 71 :S145-S149. -
di Palma A., Masini M., Cimatti G., Adamanti S., et al. Coenzyme Q10
: a probable longevity marker. Biomed. And Clin. Aspects of Q10, 6 :489-
492, 1991. -
Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Coenzyme Q10 and Coronary
Artery Disease. Clin. Investig., 1993, 71 :S112- S115. -
Judy W.V., Stogsdill W.W., Folkers K. Myocardial Preservation by
Therapy With Coenzyme Q10 During Heart Surgery. Clin. Investig., 1993, 71
:S155-S161. -
Kamei M., Fujita T., Kanbe T., Saski K., et al. The distribution and
content of ubiquinone in foods. Int. J. Vitam. Nutr. Res., 56 :1 :57-63, -
Kuklinski B., von Appen S., Weissenbacher E. Coenzyme Q10 and
Antioxidants in Acute Myocardial Infarction. 8th Int. Symp. Biomed. and
Cln. Aspects of CoQ10, 1993, s. 32. -
Mordente A., Martorana G.E., Santini S.A., Miggiano G.A.D.
Antioxidant Effect of Coenzyme Q10 on Hydrogen Peroxide-activated Myoglobin.
Clin. Investig., 1993, 71 :S92-S96. -
Morisco C., Trimarco B., Condorelli M. Effect of Coenzyme Q10 Therapy
in Patients with Congestive Heart Failure : A Long Term Multi-Centre
Randomized Study. Clin. Investig., 1993, 71 :S134- S136. -
Mortensen S.A., Vadhanavikit S., Muratsu K., Folkers K. CoQ10 :
Clinical benefits with biochem. Correlates suggesting a break through in the
management of chronic heart failure. Int. J. Tiss. Reac. : 12 :3 :155-162, -
Sugimoto M., Ideta T., Imanishi K., Ono T., et al. Effect of CoQ10 in
patients with progressive muscular dystrophy and other neuromuscular
diseases. Biomed. and Clin. Aspects of CoQ10. 1 :243-250, 1984. -
Wilkinson E.G., Arnold R.M., Folkers K. Treatment of periodontal and
other soft tissue diseases of the oral cavity with coenzyme Q. Biomed. and
Clin. Aspects of CoQ10, 1 :251 :266, 1977. -
Yamagami T., Takagi M., Akagami H., Folkers K. Effect on Q10 on
essential hypertension, a double blind controlled study. Biomed. and Clin.
Aspects of CoQ10. 5 :337-344, 1986. -
Zeppilli P., Merlino B., de Luca A., Littaru G.P., et al. Influence
of CoQ10 on physical work capacity of athletes, sedentary people and patients
with mitochondrial disease. Biomed. and Clin. Aspects of Q10.
Niet te gebruiken bij: geen gevallen gekend.
INGREDIENTEN PER CAPSULE | ||
Taurine | 300 mg | |
Tweestijlige meidoorn (Crataegus oxyacantha) | 100 mg | |
Magnesiumcitraat | 80 mg | |
Kaliumcitraat | 30 mg | |
Ginkgo biloba-extract (24% conc.) | 20 mg | |
Co-enzym Q10 (ubiquinon) | 10 mg | |
L-methionine | 250 µg | |
Hulpstoffen: gelatine, microkristallijne cellulose, magnesiumstearaat *%RI = Referentie Inname (E.C.) |